RUA Life Sciences PLC (RUA)
Industry Medical Devices
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
11.00p
Buy
12.00p
-0.50p (-4.35%)
Prices updated at 07 Apr 2025, 09:18 BST
| Prices minimum 15 mins delay
Prices in GBX
AorTech International PLC through its subsidiary is engaged in the development, exploitation & commercialization of biomedical polymer technology, components and medical devices.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
---|---|
2024 | 81.06 |
2023 | 82.19 |
2022 | 83.57 |
2021 | 81.94 |
2020 | 100.00 |
2019 | - |
2018 | - |
2017 | - |
2016 | - |
Valuation data table
Year | Price / Sales |
---|---|
2025 | 2.11 |
2024 | 2.01 |
2023 | 1.17 |
2022 | 5.32 |
2021 | 9.67 |
2020 | 28.73 |
2019 | 28.09 |
2018 | 10.04 |
2017 | 4.63 |
2016 | 2.37 |
2015 | 2.62 |
Price/Forward earnings (YTD)
16.61
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
---|---|
2024 | -20.82 |
2023 | -30.15 |
2022 | -23.25 |
2021 | -22.94 |
2020 | -29.18 |
2019 | -29.12 |
2018 | -3.06 |
2017 | -15.34 |
2016 | -26.91 |
Debt profile data table
Year | Financial leverage |
---|---|
2024 | 1.14 |
2023 | 1.21 |
2022 | 1.16 |
2021 | 1.19 |
2020 | 1.10 |
2019 | 1.03 |
2018 | 1.07 |
2017 | 1.08 |
2016 | 1.09 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.